{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP02802",
    "Peptide Name": "BacSP222 (natural AMPs; bacteriocin; Gram-positive bacteria, prokaryote; XXI; UCLL1)",
    "Source": "isolated from dog skin lesions,Staphylococcus pseudintermediusstrain 222",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "MAGLLRFLLSKGRALYNWAKSHVGKVWEWLKSGATYEQIKEWIENALGWR",
    "Sequence Length": 50,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Antifungal",
      "candidacidal",
      "Anti-MRSA"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Helix",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 5,
    "Boman Index": 1.06,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "46%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "No Cys, Pro, and Asp.  N-terminal formylated. APD analysis reveals that the sequence of this plasmid-encoded bacteriocin shows 39% similarity toS. aureus Aureocin A53.Activity: Active against B. subtilis ATCC 6633 (MIC 0.16 uM), L. lactis subsp. lactis LOCK 0871 strain 239 (MIC 0.89 uM), M. luteus ATCC 4698 (MIC 0.11 uM),  S. aureus DSM 26258 (CH91), S. aureus MRSA USA300 strain FPR3757, S. aureus KB/8658, S. aureus ATCC 25923 (MIC 0.89-1.3 uM), S. epidermidis ATCC 35547 (MIC 4.4 uM), S. intermedius ATCC 29663, S. intermedius R-2725 (MIC 1.2-2 uM), S. pseudintermedius 222, S. pseudintermedius LMG 22219 (MIC 2.1 and 0.16  uM), S. saprophyticus ATCC 15305 (MIC 0.93 uM), S. pyogenes PCM 465 (MIC 7.8 uM), S. sanguinis PCM 2335 (MIC 3.5 uM), and C. albicans ATCC 10231 (MIC 100 uM). No acitivtiy against two Gram-negative bacteria tested E.coli K12 (MIC>100 uM), K.pneumoniae ATCC 13886 (MIC>100 uM), S.marcescens ATCC 274 (MIC>100 uM. N-terminal formylation is not needed for antibacterial effects since a synthetic peptide without this modification works better.Toxicity:  HC50>100 uM (40% hemolysis at 100 uM, but at 10xMIC, 1.8% hemolysis), less hemolytic. 50% LDH release from keratinocytes (3 uM). Registered and updated 3/2017; 7/2021",
    "Author": "Wladyka B, Piejko M, Bzowska M, Pieta P, Krzysik M, Mazurek ?, Guevara-Lora I, Bukowski M, Sabat AJ, Friedrich AW, Bonar E, Mi?dzobrodzki J, Dubin A, Mak P.2015",
    "Reference": "Sci Rep. 2015 Sep 28;5:14569.PubMed",
    "Title": "A peptide factor secreted by Staphylococcus pseudintermedius exhibits properties of both bacteriocins and virulence factors"
  },
  "3D Structure": []
}